Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Rice

Podiatrist, Foot & Ankle Surgery Livingston, MT Doctor of Podiatric Medicine

NPI 1669473344 CMS profile 210980

320 Alpenglow Ln, Livingston, MT 59047

Open in the dashboard

General payments

$130,194

251 records reported · program years 2019–2025

Research payments

$622

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,736 paid to institutions, not to them · program year 2022

Through program year 2025, Andrew Rice of Livingston, MT is reported in the CMS Open Payments database as having received $130,194 across 251 general payments and $622 in research payments paid to them. Separately, studies naming them as principal investigator received $1,736 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,881 22
2024 General $502 7
2023 General $32,774 49
2022 General $36,369 72
2021 General $36,455 56
2020 General $10,061 21
2020 Research $622 1
2019 General $8,151 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Rice
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Andrew Rice were reported at $5,881. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Andrew Rice Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $8,151 $389 $118–$1,406 $163
2020 $10,061 $191 $62–$691 $114
2021 $36,455 $329 $104–$1,341 $132
2022 $36,369 $419 $125–$1,611 $149
2023 $32,774 $377 $128–$1,164 $160
2024 $502 $394 $134–$1,168 $164
2025 $5,881 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $68,894 144 payments
  2. Musculoskeletal Transplant Foundation Inc. $45,333 43 payments
  3. In2Bones USA, LLC $5,085 5 payments
  4. Baudax Bio Inc. $4,005 3 payments
  5. Linvatec Corporation $3,289 5 payments
  6. Integra LifeSciences Corporation $1,505 31 payments
  7. Avita Medical Americas, LLC $656 5 payments
  8. Globus Medical, Inc. $387 1 payment
  9. Osiris Therapeutics Inc. $276 4 payments
  10. Stryker Corporation $268 2 payments
  11. Other $496 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $51,610 29 payments
  2. Consulting Fee $39,017 14 payments
  3. Travel and Lodging $27,669 98 payments
  4. Food and Beverage $6,777 105 payments
  5. Honoraria $4,105 3 payments
  6. Grant $1,000 1 payment
  7. Education $15 1 payment
Products named General payments · program years 2019–2025
  1. STRAVIX Extremities & Limb Restoration $48,015 95 payments
  2. GRAFIX PL Other Advanced Wound Management $46,459 105 payments
  3. GRAFIX Other Advanced Wound Management $39,433 76 payments
  4. STRAVIX PL $35,248 70 payments
  5. GRAFIX Other Advanced Wound Management $16,704 26 payments
  6. GRAFIX XC Other Advanced Wound Management $12,225 28 payments
  7. GRAFIX XC Other Advanced Wound Management $11,876 17 payments
  8. STRAVIX Extremities & Limb Restoration $9,977 14 payments
  9. GRAFIX PL Other Advanced Wound Management $9,959 17 payments
  10. OASIS $4,750 5 payments
  11. Other $35,609 224 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. TissueTech, Inc. $622 1 payment

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$15,021

Medicare's payments for the services billed

Medicare patients

173

Average age 74

Services billed

317

94 women, 79 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 64%
High blood pressure 59%
Diabetes 28%
Depression 20%
Osteoporosis 18%
Ischemic heart disease 16%
Atrial fibrillation 15%
Chronic kidney disease 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

252 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Montana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record